Sign in

CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company

Ernexa Therapeutics Inc.

Sign in to watch
Ticker
ERNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
311103425
Phone
(617) 798-6700
Business address
1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
Former names
Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC

Securities

  • ERNA Common Stock Nasdaq
  • ERNAW Warrants Nasdaq
  1. 8-K Event Executive or director change
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. 8-K Event Executive or director change
  5. 4 Open-market buy Director bought 18,095 shares at an average $0.35 ($6,310)
  6. 8-K Event Executive or director change
  7. 4 Grant or award Director acquired 500,000 shares (grant or award)
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. S-8 Other Securities Offered to Employees in Benefit Plans
  11. 8-K Event Exhibits
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 8-K Event Executive or director change
  15. 4 Open-market buy Director bought 9,600 shares at $0.52 ($4,992)
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. 8-K Event Executive or director change · Shareholder vote results · Other events
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 42 of 77 · 1,525 filings